logo

Shariah compliance overview

Not Halal

Janux Therapeutics, Inc. (JANX) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Janux Therapeutics, Inc.

Janux Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative cancer therapies. The firm leverages its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to create treatments designed to activate the body's T cells to fight tumors.

Janux Therapeutics, Inc. (JANX) operates in the Healthcare sector, in the Biotechnology industry.

Why it is not classified as halal: it does not pass these screens: Business Activity, Interest-bearing securities and assets.

Business Activity
81.50%Limit 5%Fail
Interest-bearing debt
0.16%Limit 30%Pass
Interest-bearing securities and assets
65.35%Limit 30%Fail
Dividend purification
81.50%Share of dividends to give to charityPurification calculator

Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Janux Therapeutics, Inc. (JANX). Current Akinda screening label: Not Halal.